EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Pipeline & Strategy
Home
>
Innovation
>
Pipeline & Strategy
Pipeline
CanSinoBIO is dedicated in innovation and has established a diversified portfolio of product candidates preventing more than 10 diseases, demonstrating strong competitiveness.
Globally Innovative
First-in-class in China
Pre-clinical
Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menhycia® (3 months-6 years old)
13-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT dual vectors) iPneucia®
Groups A and C Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menphecia®
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Convidecia®
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation Convidecia® Air® and XBB.1.5 VARIANT
Recombinant Ebola Vaccine (Adenovirus Type 5 Vector)
Diphtheria, Tetanus and Pertussis (Acellular, Three Components) Combined Vaccine, Adsorbed for infants (below 2 years old) Tripecia®
Absorbed Tetanus Vaccine
Tetanus, Reduced Diphtheria and Pertussis (Acellular, Five Components) Combined Vaccine, Adsorbed (for people aged six years old and above)
Group ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Indication Expansion (7-59 years old)
Recombinant Poliomyelitis Vaccine
Protein-based Pneumococcal Vaccine
Recombinant Zoster Vaccine (Adenovirus Vector)
Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
Inhaled Tuberculosis Vaccine (Adenovirus Type 5 Vector)
DT3cP-Hib-MCV4 Combined Vaccine
24-valent Pneumococcal Polysaccharide Conjugate Vaccine (CRM197/TT)
mRNA Multi-valent Influenza Vaccine
Meningococcal group B Vaccine
Other Combination Vaccine Candidates
Therapeutic Vaccine Candidates
Strategy
The increasing demand for combination vaccines is expected to drive our business growth.
Meningococcal Vaccine Products
Groups A and C Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menphecia®
Groups ACYW135 Meningococcal Polysaccharide Conjugate Vaccine (CRM197) Menhycia®
CS-2023 Meningococcal vaccine
Pneumococcal Vaccine Products
PCV13i (CRM197/TT Double vector)
PBPV
CS-2028 Multivalent Pneumococcal Conjugate Vaccine
DTP Vaccine Products
DTcP Infant
Tdcp Adolescent and Adult
DTcP-Hib-MCV4 Combined Vaccine
Other
TB Booster
Recombinant Zoster Vaccine (Adenovirus Vector)
Absorbed Tetanus Vaccine
Recombinant Poliomyelitis vaccine
Haemophilus Influenzae Type b Conjugate Vaccine, Freeze-dried
Emergency Infectious Diseases Vaccine
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) Convidecia®
Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) for Inhalation Convidecia Air® and XBB.1.5 VARIANT
Ad5-EBOV